Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.11(+0.97%)
Nasdaq
19,003.65
+31.25(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
+1.08(+1.54%)
Gold
2,718.20
+43.30(+1.62%)

Silexion Therapeutics Corp (SLXN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Follow

Visitors trend2W10W

0.3070

-0.0134

(-4.18%)

At close: 04:00PM EST

0.2725

-0.03

(-11.24%)

After hours:

07:58PM EST

Split
SLXN is splitting 1:9 effective Nov. 29, 2024

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	4.43M
Enterprise Value	6.77M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	N/A
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	-0.11
52-Week Change ³	-97.17%
S&P500 52-Week Change ³	31.18%
52 Week High ³	13.5580
52 Week Low ³	0.2070
50-Day Moving Average ³	0.4145
200-Day Moving Average ³	7.6413

Share Statistics

Avg Vol (3 month) ³	5.97M
Avg Vol (10 day) ³	21.02M
Shares Outstanding ⁵	14.43M
Implied Shares Outstanding ⁶	14.43M
Float ⁸	219.74k
% Held by Insiders ¹	33.99%
% Held by Institutions ¹	8.50%
Shares Short (Oct 31, 2024) ⁴	767.74k
Short Ratio (Oct 31, 2024) ⁴	0.19
Short % of Float (Oct 31, 2024) ⁴	7.78%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	5.55%
Shares Short (prior month Sep 30, 2024) ⁴	163.76k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2013
Most Recent Quarter (mrq)	Mar 31, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	0.00%

Management Effectiveness

Return on Assets (ttm)	-62.13%
Return on Equity (ttm)	-116.66%

Income Statement

Revenue (ttm)	N/A
Revenue Per Share (ttm)	N/A
Quarterly Revenue Growth (yoy)	N/A
Gross Profit (ttm)	N/A
EBITDA	-1.35M
Net Income Avi to Common (ttm)	-1.35M
Diluted EPS (ttm)	-1.4700
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	2.78M
Total Cash Per Share (mrq)	11.1
Total Debt (mrq)	144k
Total Debt/Equity (mrq)	8.94%
Current Ratio (mrq)	3.85
Book Value Per Share (mrq)	-67.14

Cash Flow Statement

Operating Cash Flow (ttm)	-794k
Levered Free Cash Flow (ttm)	-305.62k